Product Information

ESOMEPRAZOLE DR 5 MG PACKET is a generic product labeled by Cipla USA Inc., priced at $4.3400 per EA under NDC 69097050831. Its NADAC has been published 83 times since Apr 23, 2025.

FDA first approved this application on Jan 7, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Esomeprazole magnesium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ESOMEPRAZOLE DR 5 MG PACKET

Esomeprazole magnesium
$4.3400per EA
High Outlier

Strength

5 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097050831

Classification

Generic

Dosage Form

FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA217714

FDA Approved

1/7/2025

TE Code

AB

On Market Since

1/7/2025

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for ESOMEPRAZOLE DR 5 MG PACKET has been published 83 times since Apr 23, 2025, and over the history we have for it it has declined 41.7%. The table below summarizes its recorded NADAC range and movement.

Current price$4.3400 per EA
All-time high$7.5077 (Aug 13, 2025)
All-time low$4.3400 (Nov 18, 2026)
52-week high$7.0701
52-week low$4.3400
Median price$6.8626
Average price$6.5505
Largest weekly change-8.4% (Sep 23, 2026)
Weeks tracked83
Tracking sinceApr 23, 2025

Price History

1W

-5.4%

1M

-13.3%

3M

-20.6%

6M

-28.6%

1Y

-38.6%

3Y

N/A

5Y

N/A

All

-41.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Esomeprazole magnesium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ESOMEPRAZOLE DR 5 MG PACKET?

The current National Average Drug Acquisition Cost (NADAC) for ESOMEPRAZOLE DR 5 MG PACKET, manufactured by Cipla USA Inc., is $4.3400 per EA (NDC 69097050831), effective Nov 18, 2026.

How has the price of ESOMEPRAZOLE DR 5 MG PACKET changed over time?

Over the history we have for it, the NADAC for ESOMEPRAZOLE DR 5 MG PACKET has declined 41.7%. It has been tracked across 83 weekly CMS publications since Apr 23, 2025.

What are the highest and lowest recorded NADAC prices for ESOMEPRAZOLE DR 5 MG PACKET?

Since Apr 23, 2025, the NADAC for ESOMEPRAZOLE DR 5 MG PACKET has ranged from a low of $4.3400 (Nov 18, 2026) to a high of $7.5077 (Aug 13, 2025), with a median of $6.8626 per EA.

Are there cheaper alternatives to ESOMEPRAZOLE DR 5 MG PACKET?

No other NADAC-published product currently shares the active ingredient and strength of ESOMEPRAZOLE DR 5 MG PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ESOMEPRAZOLE DR 5 MG PACKET?

ESOMEPRAZOLE DR 5 MG PACKET (NDC 69097050831) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.